Literature DB >> 28573316

[Sarcoidosis : Dermatological view of a rare multisystem disease].

T Giner1,2, S Benoit3,4, H Kneitz3, M Goebeler3.   

Abstract

Sarcoidosis is a rare multisystem inflammatory disease of largely unknown etiology. While pulmonary sarcoidosis is the most abundant organ manifestation, involvement of the skin that occurs in up to 30% of patients is the most common extrapulmonary presentation of the disease. Dermatologists therefore play an important role not only for establishing the diagnosis and delineating it from potential differential diagnoses but also for the interdisciplinary care of the patient. The clinical presentation of skin sarcoidosis is manifold, which occasionally aggravates making the final diagnosis. Specific skin lesions (with granulomas) and nonspecific skin manifestations (without granulomas) can be differentiated. Since a variety of organ systems can be affected, multidisciplinary cooperation is mandatory. Therapy of sarcoidosis is difficult; evidence-based studies and therapy guidelines are widely lacking. Our review intends to outline the characteristic clinical presentations of cutaneous sarcoidosis, describe the diagnostic approach and how to assure or exclude extracutaneous manifestations of sarcoidosis, and suggest a therapy algorithm for the treatment of skin sarcoidosis.

Entities:  

Keywords:  Differential diagnosis; Granuloma; Inflammation; Skin sarcoidosis; Therapy

Mesh:

Substances:

Year:  2017        PMID: 28573316     DOI: 10.1007/s00105-017-4005-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  37 in total

1.  Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis.

Authors:  M W Ziegenhagen; M E Rothe; M Schlaak; J Müller-Quernheim
Journal:  Eur Respir J       Date:  2003-03       Impact factor: 16.671

Review 2.  Sarcoidosis.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki; Alvin S Teirstein
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

3.  [Sarcoidosis : Organ involvement, diagnosis, current treatment].

Authors:  B Weidenthaler-Barth; K Steinbrink; A Kümmel; E von Stebut
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

4.  Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions.

Authors:  Yvette C Cozier
Journal:  Eur Respir J       Date:  2016-12       Impact factor: 16.671

5.  Disfiguring papular sarcoidosis of the face: dramatic improvement with pimecrolimus.

Authors:  M La Placa; R Balestri; C Mega; L Fasano; S Nava; A Patrizi
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-07-30       Impact factor: 6.166

6.  A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis.

Authors:  Robert J Pariser; Joan Paul; Stefanie Hirano; Cyndi Torosky; Molly Smith
Journal:  J Am Acad Dermatol       Date:  2012-12-28       Impact factor: 11.527

7.  Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas.

Authors:  E Jones; J P Callen
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

8.  Results from a genome-wide search for predisposing genes in sarcoidosis.

Authors:  M Schürmann; P Reichel; B Müller-Myhsok; M Schlaak; J Müller-Quernheim; E Schwinger
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

9.  Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients.

Authors:  Keld-Erik Byg; Nils Milman; Stig Hansen
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2003-03       Impact factor: 0.670

10.  HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis.

Authors:  Hiroe Sato; Jan C Grutters; Panagiotis Pantelidis; A Neil Mizzon; Tariq Ahmad; Arend-Jan Van Houte; Jan-Willem J Lammers; Jules M M Van Den Bosch; Kenneth I Welsh; Roland M Du Bois
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

View more
  1 in total

Review 1.  Cutaneous Granulomatosis: a Comprehensive Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Carlo Mainetti; Marie-Astrid Peeters; Emmanuel Laffitte
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.